Controlled release naproxen and naproxen sodium tablets

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4571333
SERIAL NO

06504112

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A controlled release tablet for once-daily oral administration of about 500-1200 mg of naproxen or naproxen sodium, said tablet being a homogeneous matrix comprising about 4-9 weight percent of hydroxypropylmethylcellulose having a number average molecular weight in the range of from about 80,000 to about 130,000, about 81-96 weight percent naproxen or naproxen sodium, 0.1 to about 2 weight percent of a pharmacetucailly acceptable lubricating agent, and 0 to about 8 weight percent of other pharmaceutically acceptable excipients.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNTEX PHARMACEUTICALS INTERNATONAL LIMITEDTHE CORNER HOUSE CHRUCH STREET A CORP OF BERMUDA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hsiao, Charles H Cooper City, FL 7 316
Kent, John S Palo Alto, CA 16 1505

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation